Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Sep;72(3):911–918. doi: 10.1172/JCI111062

Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin.

R Winn, J Harlan, B Nadir, L Harker, J Hildebrandt
PMCID: PMC1129256  PMID: 6886010

Abstract

The effect of dazoxiben, a selective thromboxane (Tx) synthetase inhibitor, on systemic and pulmonary hemodynamics, eicosanoids, and lung permeability was assessed in awake goats with lung lymph fistulae following infusion of Escherichia coli endotoxin (1 microgram/kg). Animals received endotoxin either with no treatment or pretreatment with a bolus (25 mg/kg) followed by a maintenance infusion (10 mg/kg per h) of dazoxiben. In untreated animals, the peak rise of 26.8 cm H2O in pulmonary artery (Ppa) and of 13.5 cm H2O in wedge (Pw) pressures occurred at the same time as the peak elevations in plasma thromboxane B2 (T X B2). Maximum reduction in cardiac output (Qt) also occurred at the same time. Lung lymph flow (QL) increased during this period and remained elevated for at least 6 h after endotoxin. T X B2 levels had returned from a peak of 13.1 to 0.7 ng/ml by 2 h. In dazoxiben-treated animals, plasma concentrations of T X B2 were never significantly elevated. Increases in Ppa and Pw were markedly reduced and decreased Qt was transient. QL in treated animals began to increase by 30 min after endotoxin and reached a peak by 2 h. Increased QL in treated animals was not as great as in the untreated animals. Moreover, lymph-plasma protein ratios increased significantly in treated animals. Plasma prostaglandin (PG)F2 alpha and 6-keto-PGF1 alpha concentrations were elevated in both groups after endotoxin with values significantly greater in treated animals. We conclude that selective inhibition of Tx ameliorates many adverse hemodynamic consequences of endotoxemia but does not prevent lung permeability changes.

Full text

PDF
911

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson F. L., Jubiz W., Tsagaris T. J., Kuida H. Endotoxin-induced prostaglandin E and F release in dogs. Am J Physiol. 1975 Feb;228(2):410–414. doi: 10.1152/ajplegacy.1975.228.2.410. [DOI] [PubMed] [Google Scholar]
  2. Anderson F. L., Tsagaris T. J., Jubiz W., Kuida H. Prostaglandin F and E levels during endotoxin-induced pulmonary hypertension in calves. Am J Physiol. 1975 May;228(5):1479–1482. doi: 10.1152/ajplegacy.1975.228.5.1479. [DOI] [PubMed] [Google Scholar]
  3. Brigham K. L., Bowers R. E., McKeen C. R. Methylprednisolone prevention of increased lung vascular permeability following endotoxemia in sheep. J Clin Invest. 1981 Apr;67(4):1103–1110. doi: 10.1172/JCI110123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brigham K. L., Bowers R., Haynes J. Increased sheep lung vascular permeability caused by Escherichia coli endotoxin. Circ Res. 1979 Aug;45(2):292–297. doi: 10.1161/01.res.45.2.292. [DOI] [PubMed] [Google Scholar]
  5. Brigham K. L., Woolverton W. C., Blake L. H., Staub N. C. Increased sheep lung vascular permeability caused by pseudomonas bacteremia. J Clin Invest. 1974 Oct;54(4):792–804. doi: 10.1172/JCI107819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cook J. A., Wise W. C., Halushka P. V. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J Clin Invest. 1980 Jan;65(1):227–230. doi: 10.1172/JCI109655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Demling R. H. Role of prostaglandins in acute pulmonary microvascular injury. Ann N Y Acad Sci. 1982;384:517–534. doi: 10.1111/j.1749-6632.1982.tb21397.x. [DOI] [PubMed] [Google Scholar]
  8. Erdmann A. J., 3rd, Vaughan T. R., Jr, Brigham K. L., Woolverton W. C., Staub N. C. Effect of increased vascular pressure on lung fluid balance in unanesthetized sheep. Circ Res. 1975 Sep;37(3):271–284. doi: 10.1161/01.res.37.3.271. [DOI] [PubMed] [Google Scholar]
  9. Erdös E. G., Hinshaw L. B., Gill C. C. Effect of indomethacin in endotoxin shock in the dog. Proc Soc Exp Biol Med. 1967 Jul;125(3):916–919. doi: 10.3181/00379727-125-32239. [DOI] [PubMed] [Google Scholar]
  10. Fletcher J. R., Ramwell P. W. Altered lung metabolism of prostaglandins during hemorrhagic and endotoxin shock. Surg Forum. 1977;28:184–186. [PubMed] [Google Scholar]
  11. Fletcher J. R., Ramwell P. W. E. coli endotoxin shock in the dog; treatment with lidocaine or indomethacin. Br J Pharmacol. 1978 Oct;64(2):185–191. doi: 10.1111/j.1476-5381.1978.tb17288.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fletcher J. R., Ramwell P. W. Indomethacin improves survival after endotoxin in baboons. Adv Prostaglandin Thromboxane Res. 1980;7:821–828. [PubMed] [Google Scholar]
  13. Fletcher J. R., Ramwell P. W. Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog. Br J Pharmacol. 1977 Oct;61(2):175–181. doi: 10.1111/j.1476-5381.1977.tb08402.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hsu C. C., Wu S. J., Celic L., Weaver L. J., Solliday N. Increased proportion of active sheep erythrocyte rosette-forming lymphocytes and plasma rosette enhancement in sarcoidosis. Am Rev Respir Dis. 1979 Mar;119(3):383–389. doi: 10.1164/arrd.1979.119.3.383. [DOI] [PubMed] [Google Scholar]
  15. Hüttemeier P. C., Watkins W. D., Peterson M. B., Zapol W. M. Acute pulmonary hypertension and lung thromboxane release after endotoxin infusion in normal and leukopenic sheep. Circ Res. 1982 May;50(5):688–694. doi: 10.1161/01.res.50.5.688. [DOI] [PubMed] [Google Scholar]
  16. Kinsman R. A., Yaroush R. A., Fernandez E., Dirks J. F., Schocket M., Fukuhara J. Symptoms and experiences in chronic bronchitis and emphysema. Chest. 1983 May;83(5):755–761. doi: 10.1378/chest.83.5.755. [DOI] [PubMed] [Google Scholar]
  17. Lefer A. M., Smith E. F., 3rd, Araki H., Smith J. B., Aharony D., Claremon D. A., Magolda R. L., Nicolaou K. C. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1706–1710. doi: 10.1073/pnas.77.3.1706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. NORTHOVER B. J., SUBRAMANIAN G. Analgesic-antipyretic drugs as antagonists of endotoxin shock in dogs. J Pathol Bacteriol. 1962 Apr;83:463–468. [PubMed] [Google Scholar]
  19. Parratt J. R., Sturgess R. M. The effect of indomethacin on the cardiovascular and metabolic responses to E. coli endotoxin in the cat. Br J Pharmacol. 1974 Feb;50(2):177–183. doi: 10.1111/j.1476-5381.1974.tb08559.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Parratt J. R., Sturgess R. M. The protective effect of sodium meclofenamate in experimental endotoxin shock. Br J Pharmacol. 1975 Mar;53(3):466P–466P. [PMC free article] [PubMed] [Google Scholar]
  21. Pontoppidan H., Geffin B., Lowenstein E. Acute respiratory failure in the adult. 1. N Engl J Med. 1972 Oct 5;287(14):690–698. doi: 10.1056/NEJM197210052871404. [DOI] [PubMed] [Google Scholar]
  22. Randall M. J., Parry M. J., Hawkeswood E., Cross P. E., Dickinson R. P. UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity. Thromb Res. 1981 Jul 1;23(1-2):145–162. doi: 10.1016/0049-3848(81)90247-4. [DOI] [PubMed] [Google Scholar]
  23. Stothert J. C., Jr, Winn R., Nadir B., Weaver L. J., Carrico C. J., Hildebrandt J. Modified chronic lung lymph fistula in goats via thoracic duct. J Appl Physiol Respir Environ Exerc Physiol. 1981 Jul;51(1):226–228. doi: 10.1152/jappl.1981.51.1.226. [DOI] [PubMed] [Google Scholar]
  24. Tyler H. M., Saxton C. A., Parry M. J. Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase. Lancet. 1981 Mar 21;1(8221):629–632. doi: 10.1016/s0140-6736(81)91551-8. [DOI] [PubMed] [Google Scholar]
  25. Vermylen J., Defreyn G., Carreras L. O., Machin S. J., Van Schaeren J., Verstraete M. Thromboxane synthetase inhibition as antithrombotic strategy. Lancet. 1981 May 16;1(8229):1073–1075. doi: 10.1016/s0140-6736(81)92241-8. [DOI] [PubMed] [Google Scholar]
  26. Watkins W. D., Hüttemeier P. C., Kong D., Peterson M. B. Thromboxane and pulmonary hypertension following E. coli endotoxin infusion in sheep: effect of an imidazole derivative. Prostaglandins. 1982 Mar;23(3):273–285. doi: 10.1016/0090-6980(82)90073-9. [DOI] [PubMed] [Google Scholar]
  27. Winn R., Nadir B., Gleisner J., Hildebrandt J. Chronic lung lymph fistula in the goat. J Appl Physiol Respir Environ Exerc Physiol. 1980 Feb;48(2):399–402. doi: 10.1152/jappl.1980.48.2.399. [DOI] [PubMed] [Google Scholar]
  28. Wise W. C., Cook J. A., Eller T., Halushka P. V. Ibuprofen improves survival from endotoxic shock in the rat. J Pharmacol Exp Ther. 1980 Oct;215(1):160–164. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES